NCT02473497 2024-06-26Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric PatientsPfizerNo longer available
NCT06238583 2024-02-02Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their DoctorsBayerNo longer available
NCT04869501 2023-04-28Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic CancerI-Mab Biopharma US LimitedNo longer available
NCT03206931 2021-09-16Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene FusionBayerNo longer available